Third INTERMACS Annual Report: The evolution of destination therapy in the United States

JOURNAL OF HEART AND LUNG TRANSPLANTATION

卷:30

Article

Kirklin, James K.¹  Kormos, Robert L.²  Stevenson, Lynne W.³  Pagani, Francis D.⁴  Ulisney, Karen L.⁵  Baldwin, J. Timothy⁶  Young, James B.⁷ 

[1] Univ Alabama, Div Cardiovasc, Birmingham, AL 35294 USA

[2] Univ Pittsburgh, Med Ctr, Presbyterian Univ Hosp, Pittsburgh, PA USA

[3] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA

[4] Univ Michigan, Ann Arbor, MI 48109 USA

[5] NHLBI, NIH, Div Cardiovasc Dis, Adv Technol & Surg Branch, Bethesda, MD 20892 USA

[6] NHLBI, Rockledge Ctr 2, Bethesda, MD 20892 USA

[7] Cleveland Clin Fdn, Lerner Coll Med, Cleveland, OH 44195 USA

关键词: mechanical circulatory support;    destination therapy;    INTERMACS;    LVAD;    advanced heart failure;   

DOI  :  10.1016/j.healun.2010.12.001

来源: Elsevier

【 摘 要 】

The third annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) provides documentation of the current landscape of durable mechanical circulatory support in the United States. With nearly 3,000 patients entered into the database, the transition to continuous-flow pump technology is evident and dramatic. This report focuses on the rapidly expanding experience with mechanical circulatory support as destination therapy. The current I-year survival of 75% with continuous-flow destination therapy provides a benchmark for the evolving application of this therapy. J Heart Lung Transplant 2011;30:115-23 (C) 2011 International Society for Heart and Lung Transplantation. All rights reserved.

【 授权许可】

Free